Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, The Netherlands.
Blood. 2011 Nov 10;118(19):5211-7. doi: 10.1182/blood-2011-04-342998. Epub 2011 Sep 14.
The pathogenesis of classical Hodgkin lymphoma (cHL) involves environmental and genetic factors. To explore the role of the human leukocyte antigen (HLA) genes, we performed a case-control genotyping study in 338 Dutch cHL patients and more than 5000 controls using a PCR-based sequence-specific oligonucleotide probe hybridization approach. HLA-A68 and HLA-DR11 (5) were significantly increased in the cHL patient population compared with the controls. Three class II associations were observed in the EBV(-) cHL population with an increase of HLA-DR15 (2) and a decrease of HLA-DR4 and HLA-DR7. Allele frequencies of HLA-A1, HLA-B37, and HLA-DR10 were significantly increased in the EBV(+) cHL population; these alleles are in strong linkage disequilibrium and form a common haplotype in whites. The allele frequency of HLA-A2 was significantly decreased in the EBV(+) cHL population. Sequence-specific oligonucleotide probe analysis revealed significant differences between EBV(+) and EBV(-) cHL patients for 19 probes that discriminate between HLA-A01 and HLA-A02. In conclusion, the HLA-A1 and HLA-A2 antigens and not specific single nucleotide variants shared by multiple alleles are responsible for the association with EBV(+) cHL. Furthermore, several new protective and predisposing HLA class I and II associations for the EBV(+), the EBV(-), and the entire cHL population were identified.
经典霍奇金淋巴瘤(cHL)的发病机制涉及环境和遗传因素。为了探讨人类白细胞抗原(HLA)基因的作用,我们使用基于 PCR 的序列特异性寡核苷酸探针杂交方法,在 338 名荷兰 cHL 患者和 5000 多名对照中进行了病例对照基因分型研究。与对照组相比,cHL 患者人群中 HLA-A68 和 HLA-DR11(5)明显增加。在 EBV(-) cHL 人群中观察到三个 II 类关联,HLA-DR15(2)增加,HLA-DR4 和 HLA-DR7 减少。在 EBV(+) cHL 人群中,HLA-A1、HLA-B37 和 HLA-DR10 的等位基因频率明显增加;这些等位基因在白人中存在强连锁不平衡,形成常见的单倍型。在 EBV(+) cHL 人群中,HLA-A2 的等位基因频率明显降低。序列特异性寡核苷酸探针分析显示,在 EBV(+) 和 EBV(-) cHL 患者之间,有 19 个探针存在显著差异,这些探针可区分 HLA-A01 和 HLA-A02。总之,与 EBV(+) cHL 相关的是 HLA-A1 和 HLA-A2 抗原,而不是多个等位基因共有的特定单核苷酸变异。此外,还确定了针对 EBV(+)、EBV(-) 和整个 cHL 人群的几个新的保护性和易感性 HLA I 类和 II 类关联。